Recent advancements in cancer treatment have brought forth a new experimental drug known as elraglusib, which has significantly improved one-year survival rates for pancreatic cancer patients, a disease notorious for
Recent advancements in cancer treatment have brought forth a new experimental drug known as elraglusib, which has significantly improved one-year survival rates for pancreatic cancer patients, a disease notorious for
British patients are preparing for a technological leap as Elon Musk’s Neuralink begins its maiden clinical trials in the United Kingdom. With approvals from UK medical regulators now secured, the






